TXG
10X Genomics Inc
NASDAQ: TXG · HEALTHCARE · HEALTH INFORMATION SERVICES
$20.50
-7.34% today
Updated 2026-06-05
Market cap
$3.66B
P/E ratio
—
P/S ratio
5.73x
EPS (TTM)
$-0.17
Dividend yield
—
52W range
$10 – $36
Volume
2.7M
10X Genomics Inc (TXG) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$20.50
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$61.17
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.5B | $0.5B | $0.6B | $0.6B | $0.6B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -3.55%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.